If you added up all the sun exposure the average woman gets in a year, roughly 60 percent of it happens between May and September. Four months, most of the damage. This is what dermatologists call the "summer bill" — the accumulated UV load that shows up years later as fine lines, uneven pigmentation, and the specific quality of skin we've come to call "aged."
At JenSkin we don't sell sunscreen. We think about sun exposure the way we think about the other markers on the panel: as a load that adds up over decades, and that you can dramatically reduce with a few boring, high-leverage choices.
Here's what happens in your skin when you are outside in July, and what the research actually recommends.
The two kinds of UV, and why one matters more for aging.
Ultraviolet light comes to your skin in two main wavelengths.
UVB is the shorter one. It causes visible sunburn. It penetrates the top layers of skin and damages DNA at the surface. This is the wavelength most associated with skin cancer risk.
UVA is longer. It doesn't burn visibly, but it penetrates deeper into the dermis — where your collagen and elastin live. UVA is the wavelength that drives most of what we visibly call "photoaging."
For most of the twentieth century, sunscreens protected primarily against UVB. That's what SPF measures. UVA protection is a separate rating — in the US, look for the words "broad spectrum" on the label. This is why "wearing sunscreen every day" as an anti-aging habit only started producing meaningful results after broad-spectrum formulations became widespread in the 2000s.
If your sunscreen does not say "broad spectrum," it is protecting you from cancer risk but not fully from aging.
What actually happens at the cellular level.
When UV hits your skin, four things happen.
Direct DNA damage. UVB damages nucleotides directly. UVA does it indirectly through free radicals. Your cells have a repair crew that fixes most of this damage — but the repair crew is imperfect and gets slower as you age.
Free radical generation. UVA in particular generates enormous amounts of free radicals in the dermis. This is one of the largest daily contributors to the oxidized LDL and oxidative stress we measure on the JenSkin panel. Every hour in the sun without protection is dumping oxidative load into the system.
MMP activation. UV triggers the same matrix metalloproteinases we've written about in the hsCRP article — the enzymes that break down collagen and elastin. A day at the pool without sunscreen produces a measurable spike in MMP activity sustained for 24 to 48 hours after exposure.
Inflammation. Sun-damaged skin is inflamed skin. That inflammation is systemic, not just local. Chronic summer sun exposure without protection contributes to the hsCRP baseline we measure in our customers.
The vitamin D tradeoff.
Sunscreen blocks the wavelength your skin uses to make vitamin D. This is a real tradeoff and it's why we've written about vitamin D separately.
The current best evidence: fifteen minutes of direct sun exposure on arms and legs (not face) three times a week is enough for most people to maintain skin-based vitamin D production without meaningful skin aging risk. Everything beyond that is a cost-benefit conversation that lands in favor of supplementation.
For most women, the practical answer is: sunscreen on the face and neck every day, and either short unprotected exposure on limbs or vitamin D supplementation. Both are reasonable. Neither is optional if you live above the 37th parallel.
What the research says about daily SPF.
The most important paper here is Hughes and colleagues, 2013, in Annals of Internal Medicine. They followed 903 adults for 4.5 years. Half were told to apply broad-spectrum SPF 15 or higher daily. Half were told to use it as they normally would. At the end of the trial, the daily-use group showed 24 percent less skin aging progression than the control group — measured by imaging, quantitatively.
This is one of the largest, longest, best-run trials in dermatology. Its finding is worth internalizing: daily sunscreen is one of the very few skincare choices with a controlled trial showing real anti-aging benefit.
What to actually do this summer.
Every morning: broad-spectrum SPF 30 or higher on face, neck, décolletage, and any exposed skin. Reapply every two hours if you are outside for extended periods. The best sunscreen is the one you will actually put on — mineral, chemical, tinted, whatever you'll use consistently.
Between 10 AM and 4 PM in peak summer: treat direct sun the way you would treat any accumulating cost. Shade when possible. Hats when practical. Long sleeves for extended outdoor time. This isn't fear-based — it's just accounting.
After sun exposure: your skin has just taken oxidative damage. This is a good day to lean into antioxidant-rich foods (berries, colorful vegetables, green tea) and to make sure your omega-3 index is where you want it.
Watch for the compound effect. One sunny day doesn't matter. A summer of many sunny days does. A decade of many summers is where the aging you'll see in your fifties actually accrues.
The frame.
If we could make one behavior universal across our customer base tomorrow, it would be daily broad-spectrum SPF. Every other intervention on the JenSkin panel is downstream of the sun exposure you're taking on top of it.
Nothing else in dermatology has the risk-benefit profile of sunscreen. It is the closest thing skincare has to a proven, cheap, universally-applicable intervention.
Use it.
References.
- Hughes MC, Williams GM, Baker P, Green AC. "Sunscreen and prevention of skin aging: a randomized trial." Annals of Internal Medicine. 2013;158(11):781-790.
- Krutmann J, Bouloc A, Sore G, Bernard BA, Passeron T. "The skin aging exposome." Journal of Dermatological Science. 2017;85(3):152-161.
- Randhawa M, Wang S, Leyden JJ, et al. "Daily use of a facial broad spectrum sunscreen over one-year significantly improves clinical evaluation of photoaging." Dermatologic Surgery. 2016;42(12):1354-1361.
- Kohl E, Steinbauer J, Landthaler M, Szeimies RM. "Skin ageing." Journal of the European Academy of Dermatology and Venereology. 2011;25(8):873-884.
